India
· Delayed Price · Currency is INR Amrutanjan Health Care Statistics
Total Valuation
NSE:AMRUTANJAN has a market cap or net worth of INR 20.83 billion. The enterprise value is 18.86 billion.
| Market Cap | 20.83B |
| Enterprise Value | 18.86B |
Important Dates
The last earnings date was Monday, August 11, 2025.
| Earnings Date | Aug 11, 2025 |
| Ex-Dividend Date | Sep 16, 2025 |
Share Statistics
| Current Share Class | 28.91M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.07% |
| Shares Change (QoQ) | +0.17% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 12.97M |
Valuation Ratios
The trailing PE ratio is 38.20.
| PE Ratio | 38.20 |
| Forward PE | n/a |
| PS Ratio | 4.51 |
| PB Ratio | 6.38 |
| P/TBV Ratio | 6.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 34.59 |
| EV / Sales | 4.08 |
| EV / EBITDA | 29.42 |
| EV / EBIT | 32.40 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.03 |
| Debt / FCF | n/a |
| Interest Coverage | 282.46 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 11.76% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 6.27M |
| Profits Per Employee | 739,896 |
| Employee Count | 737 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:AMRUTANJAN has paid 195.48 million in taxes.
| Income Tax | 195.48M |
| Effective Tax Rate | 26.39% |
Stock Price Statistics
The stock price has decreased by -6.89% in the last 52 weeks. The beta is 0.40, so NSE:AMRUTANJAN's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | -6.89% |
| 50-Day Moving Average | 712.28 |
| 200-Day Moving Average | 689.86 |
| Relative Strength Index (RSI) | 44.57 |
| Average Volume (20 Days) | 26,642 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:AMRUTANJAN had revenue of INR 4.62 billion and earned 545.30 million in profits. Earnings per share was 18.84.
| Revenue | 4.62B |
| Gross Profit | 2.28B |
| Operating Income | 582.14M |
| Pretax Income | 740.78M |
| Net Income | 545.30M |
| EBITDA | 637.59M |
| EBIT | 582.14M |
| Earnings Per Share (EPS) | 18.84 |
Balance Sheet
The company has 1.99 billion in cash and 20.78 million in debt, giving a net cash position of 1.97 billion.
| Cash & Cash Equivalents | 1.99B |
| Total Debt | 20.78M |
| Net Cash | 1.97B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 3.27B |
| Book Value Per Share | 112.98 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 49.31%, with operating and profit margins of 12.59% and 11.80%.
| Gross Margin | 49.31% |
| Operating Margin | 12.59% |
| Pretax Margin | 16.02% |
| Profit Margin | 11.80% |
| EBITDA Margin | 13.79% |
| EBIT Margin | 12.59% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 3.60, which amounts to a dividend yield of 0.50%.
| Dividend Per Share | 3.60 |
| Dividend Yield | 0.50% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.07% |
| Shareholder Yield | 0.43% |
| Earnings Yield | 2.62% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 13, 2018. It was a forward split with a ratio of 2.
| Last Split Date | Apr 13, 2018 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |